Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125042242 | 12504224 | 2 | F | 201606 | 20160713 | 20160628 | 20160719 | EXP | JP-ELI_LILLY_AND_COMPANY-JP201606008905 | ELI LILLY AND CO | 65.00 | YR | Y | 0.00000 | 20160718 | CN | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125042242 | 12504224 | 1 | PS | CYRAMZA | RAMUCIRUMAB | 1 | Intravenous (not otherwise specified) | 8 MG/KG, OTHER | Y | 125477 | 8 | MG/KG | INJECTION | ||||||
| 125042242 | 12504224 | 2 | SS | PACLITAXEL. | PACLITAXEL | 1 | Intravenous (not otherwise specified) | 80 MG/M2, OTHER | Y | 0 | 80 | MG/M**2 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125042242 | 12504224 | 1 | Gastric cancer |
| 125042242 | 12504224 | 2 | Gastric cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125042242 | 12504224 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125042242 | 12504224 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125042242 | 12504224 | 1 | 20160607 | 20160607 | 0 | |
| 125042242 | 12504224 | 2 | 20160607 | 0 |